Abstract
purpose. To identify the risk factors for having advanced glaucomatous visual
field loss on the first visit at three hospital eye services.
methods. This was a hospital-based, case–control study involving patients newly
diagnosed with glaucoma at first visit to one of three ophthalmic
departments in the United Kingdom. Patients with a previous history of
ocular hypertension or any documented suspicion of glaucoma (within the
hospital eye service) were excluded.
results. Occupational group, initial intraocular pressure (IOP), family history
of glaucoma, method of referral to hospital, and the number of years
since the last visit to an optometrist were found to be independently
associated with late presentation. A linear trend of increasing odds of
late attendance was associated with increasing Standard Occupational
Classification. Those in managerial (category II) and skilled (category
III) groups estimated (95% confidence intervals) to be, respectively,
0.2 (0.00, 0.16) and 0.27 (0.1, 0.8) as likely to attend with
advanced glaucomatous field loss as unskilled (category V) people with
similar initial IOP, family history, referral route, and time since
last optometrist visit. The data strongly suggest an association
between IOP and advanced field loss at initial hospital examination.
There was a 1.2 (1.12, 1.28) increase in the OR of late presentation
per unit increase in millimeters of mercury after adjustment for the
other mentioned factors. People with a family history of glaucoma were
estimated to be almost one third (adjusted OR, 0.29 [0.12, 0.74]) as
likely to have advanced field loss as those with no family history.
People referred by any source other than an optometrist who has made
the correct diagnosis of glaucoma were 4.5 times (adjusted OR, 4.53[
1.52, 13.48]) more likely to be late attenders than patients so
referred but similar in other mentioned factors. These data also
provide strong evidence that the more years since the last visit to an
optometrist, the greater the likelihood of having advanced glaucomatous
visual field loss on the first visit to the eye service (adjusted OR
per year, 1.25 [1.10, 1.42]).
conclusions. These data strongly suggest that certain subgroups of people with
glaucoma were at greater risk of having advanced and irremediable field
loss on first visiting the eye services
studied.
Glaucoma is a disease with major public health implications. It
is known to afflict approximately 2% of white people aged 40 or more
and at occurs in at least four times that many African Americans and
African Caribbeans.
1 Populations are aging, and the
increase in the prevalence of glaucoma with increasing age has been
well documented.
1 2
Despite new medical and surgical strategies to control intraocular
pressure (IOP), blindness registration from glaucoma continues to
increase, and glaucoma remains the second or third most common cause of
blindness in the world.
3 4
Why do people become blind from glaucoma? Grant and Burke
5 have suggested that there are two reasons: 1) People seek medical
attention late in the course of the disease, when the rate of visual
field loss is increased, and there is less field left to lose. 2)
People seek help early but receive suboptimal treatment.
Published work on the first of these reasons—late presentation—is
scarce. This study was conducted to examine this and to attempt to
identify the factors that put a person at risk of having advanced
glaucomatous visual field loss on the first visit to the hospital eye
service (HES).
To be considered for the study, all patients had 1) visual field
loss that was consistent with a known pattern of glaucomatous cause
(e.g., arcuate scotomas), was compatible with the patient’s disc
changes and in which there was no suggestion of other optic nerve
disease (e.g., defects that crossed the horizontal midline); 2)
Glaucoma of any chronic type: primary open-angle, pseudoexfoliative,
normal tension, chronic angle closure, aphakic, or pigment dispersion;
and 3) two consecutive fields (threshold or suprathreshold) confirming
the loss, except when field loss was so advanced that perimetry was not
possible. 4) Patients who had more than one-third loss of fixation or
false-positive or false-negative results on the initial visual field
test were not enrolled. Fields were examined almost exclusively with
the Humphrey (San Leandro, CA) 24-2 or 10-2 threshold strategies.
If the patients fit these criteria then a decision was made about
whether they could be cases or controls, based on visual field and
optic disc anomalies. Cases were defined as fulfilling the above
criteria but having field loss within 5° of fixation and beyond 30°
in one or both eyes and with a cup-to-disc ratio greater than 0.8 in
the same eye. Controls were defined as fulfilling the above criteria
but with the visual field having no absolute scotomas within 20° of
fixation in either eye and a cup-to-disc ratio assessed as higher than
0.5 or a difference of more than 0.2 between the discs.
In an attempt to minimize the problems of recall bias, patients were
recruited after the first field examination. If, during follow-up,
visual fields improved to the extent that the patient no longer met the
criteria, they were removed from the study. Six patients were excluded
on this basis, each after their second visual field trial. The disc
parameter criteria were shown, by pilot study, to be sensitive
indicators of cases and controls.
Basic demographic, referral, and ophthalmic information was collected
at the initial consultation, and suitable patients consented to further
evaluation. These patients were then telephoned by an interviewer
masked to their case–control status, who validated demographic data
and asked a series of standard questions regarding socioeconomic
status, general medical health, and attendance and use of sight testing
(i.e., optometrist) services.
For each patient identified as eligible for the study, the following
information was collected: Age when first assessed by the
ophthalmologist, sex, ethnic origin (white, all those from the United
Kingdom and Ireland; black, African and African Caribbean; Asian, from
the Indian subcontinent); coexisting ocular or medical disease; IOP
according to the standard Goldmann tonometer reading at initial
examination; frequency of sight testing; and Standard Occupational
Classification.
The study was undertaken over a 9-month period from September 1996
through May 1997 and was discontinued when 110 cases and 110 controls
had been reviewed. None of the patients who fit the study criteria
declined to take part in the study, and there was no loss of patients
during the study.
Table 2 shows the characteristics of the study population. The median
(interquartile range; IQR) age of controls was 63 years (IQR, 52–71
years) and of cases was 72 years (IQR, 63–78 years). Similar numbers
of men and women were studied. Most (
n = 171) of the
patients recruited were white, 35 were of African or African Caribbean
origin, and 14 were of Asian origin. The most common diagnosis was
primary open angle glaucoma (
n = 155) followed by
normal tension glaucoma (
n = 27). Fifteen patients had
diagnoses of pseudoexfoliative glaucoma, and 13 of chronic
angle-closure glaucoma. The median IOP in right eyes was 24 mm Hg (IQR,
22–30 mm Hg) and in left eyes was 25 mm Hg (IQR, 22–30 mm Hg). The
median maximum IOP (i.e., the higher of the right and left IOPs at
initial examination) was 26 mm Hg (IQR, 23–31.5 mm Hg). Most subjects
had no significant ongoing medical problems. Of those who reported
problems, systemic hypertension was the most common disorder. Most
subjects (
n = 155) had no family history of glaucoma,
31 had a single first-degree relative with glaucoma, 14 had a
second-degree relative with glaucoma, and 20 had two or more
first-degree relatives with glaucoma. The majority (
n =
163) of patients were referred from optometrists who had made a
presumptive diagnosis of glaucoma.
Table 2 also shows that most
subjects had visited an optometrist no more than 5 years before the
referral visit. Thirty-one subjects had either never seen an
optometrist or had not seen one for more than 10 years.
Tables 2 and 3 show the estimated effect of each study factor on late attendance. The
data provide strong evidence of independent associations between late
attendance and the model I variables occupational group, maximum
measured IOP, family history, referral source, and time since last
visit to the optometrist.
We estimated a linear trend of increasing odds of late attendance with
increasing occupational group. Patients of managerial (category II) and
skilled (category III) occupations were estimated (95% confidence
intervals) to be, respectively, 0.2 (0.00, 0.16) and 0.27 (0.1, 0.8) as
likely to have advanced glaucomatous field loss at the first visit to
the eye service as patients who were in unskilled occupations but were
similar in IOP, family history, referral source, and time since last
visit to an optometrist. The statistical nonsignificance of the other
occupational OR estimates may be a reflection of low power, with only
15% of patients classified in categories I and II.
Maximum IOP (i.e., the greater of the right and left IOPs) at initial
examination was shown by these data to be strongly associated with the
odds of having advanced field loss. We estimate a 1.2 (1.11, 1.28)
increase in the odds of late attendance per increased millimeter of
mercury after adjustment for model I factors.
The stronger the patient’s family history, the lower the odds of late
attendance. Overall, a patient with a family history of glaucoma was
estimated to be almost one third (0.29 [0.12, 0.74]) as likely to
attend with advanced field loss as a patient with no family history but
of the same occupational group and referral source and similar IOP and
time since last visit to an optometrist.
Referral source is shown by these data to be strongly associated
with late attendance. A patient referred through any source other than
an optometrist who had made the correct diagnosis was estimated to be
4.5 times (4.53 [1.52, 13.48]) more likely to be a late attender than
a patient so referred but similar in other model I variables. These
data provide strong evidence that the greater the number of years since
last visiting an optometrist, the greater the likelihood of delaying
attendance at the eye service. (adjusted OR per year, 1.25 [1.10,
1.42]).
Univariate analysis suggested a strong association between ethnic
origin and late attendance, estimating that people of African Caribbean
origin were more than six times likely to attend with advanced field
loss than were white patients. Ethnic origin was not, however,
statistically significant in the multivariate model. Inspection of a
partial correlation matrix of all study factors revealed moderate
correlation between ethnic origin and referral source and number of
years since last visit to an optometrist. Much of the apparent effect
of ethnicity on late attendance appeared to be caused by less frequent
sight testing. However the statistical nonsignificance may well have
been a consequence of relatively low power. These data provided little
evidence of association between late attendance and any of the other
factors studied.
Several investigators have shown that patients who have advanced
glaucoma are at a substantial risk of blindness.
5 8 9 10 11 12 Grant and Burke
5 found that eyes with a visual field
defect at the beginning of treatment are more likely to progress to
blindness than eyes in which treatment is started at the stage when
there is no field loss (although whether all the patients in the second
group in their study had glaucoma is difficult to ascertain). Wilson et
al.
8 looked at risk factors for rate of progression of
glaucomatous visual field loss in 57 patients and found that visual
field loss at initial examination was the strongest determinant of rate
of further visual field loss. Patients in their study deteriorated 11.7
times faster in eyes with more advanced field loss. Mikelburg et
al.
12 measured the scotoma mass of fields and compared
them with the rate of subsequent decline. They found that when scotoma
mass is small (i.e., early disease), rate of visual field loss is slow,
but when the scotoma mass is large, rapid linear progression of visual
fields loss occurs.
Thus, there is good (if inferential) evidence that late attendance
(i.e., after substantial field loss) is a significant risk factor for
subsequent blindness caused by glaucoma. There is also a biologic
plausibility underpinning this, in that the fewer axons the optic nerve
has, the fewer it can afford to lose without significant field changes.
Another important aspect of late attendance that should be examined is
the extent of the problem. Late attendance may be important to the
patient, but does it occur in significant numbers?
There have been a number of studies that have estimated the proportion
of patients with glaucoma who have substantial visual field loss. Grant
and Burke
5 calculated that one third of the patients who
had become blind from glaucoma had done so before they had sought
medical attention for their eyes. Elkington et al.
13 reported a figure of 33% delaying medical attention, a study in the
west of Ireland
14 found 10% of those with glaucoma were
severely visually impaired at first examination, and Sheldrick et
al.
15 showed 20% with severe impairment. The published
evidence seems to indicate that late presentation of glaucoma is an
important and not uncommon risk factor for blindness. This study was an
attempt to elucidate the risk factors for late presentation.
It was suggested in our pilot study that whether a person seeks
attention late in the course of glaucoma is likely to be a function of
the rapidity of visual field deterioration and the frequency of sight
tests.
16 A person with a rapid decline could lose
significant field even with two yearly sight tests, unless tested
during an early but detectable phase of the disease. Conversely, a
person with a slowly declining field but who does not have sight
testing for some years (or does not have a glaucoma examination during
the sight tests) is at risk for a different reason. The pilot study
found evidence to support this, but the findings were limited by the
retrospective nature of the data collection. Do the results of this
present study support the results of the pilot study?
Consistent with our earlier pilot study, these data provide strong
evidence (
P < 0.05) of an association between maximum
IOP at initial examination and the odds of late attendance. There is
evidence in the literature that higher IOPs lead to more rapid visual
field loss (and thus increased likelihood of delayed attendance). David
et al.,
17 Hart et al.,
18 and Armaly et
al.
19 all found more rapid visual field loss at higher
levels of IOP. Jay and Murdoch
20 calculated that for
pressures of 21 to 25 mm Hg, untreated disease was likely to progress
from early field changes to end stage in approximately 14 years,
whereas for pressures higher than 30 mm Hg the interval to end-stage
disease was as short as 3 years.
Related to this are the results from the category of glaucoma
diagnosis.
Tables 2 and 3 show that patients with pseudoexfoliative and
chronic angle-closure glaucoma were in fact all categorized as cases
(producing infinite odds ratios). Because these conditions are usually
associated with higher IOPs than primary open-angle glaucoma, this is a
further indication that those with higher IOPs are more likely to
attend late.
Our results support the concept that those expected to have a rapid
visual field decline (i.e., those with higher IOPs at the first visit)
are at risk of having advanced visual field loss at initial examination
in the eye service. Are the results also consistent with the
alternative reason for patients’ attending late—that of infrequent
sight testing?
In the United Kingdom, the optometrist plays a pivotal role in glaucoma
detection. One study showed that 90% of patients with glaucoma are
referred to the hospital on the basis of abnormal findings by an
optometrist.
15 Our results estimate that a patient who had
not been correctly referred to the hospital by an optometrist was 4.5
times more likely to attend late than a comparable patient who had been
properly referred. This result is very similar to that found in the
pilot study.
16
Referral source appears to be an important factor in early attendance,
with patients referred from optometrists with a diagnosis of glaucoma
more likely to be in the earlier stages of the disease. This suggests
one of two things: that those who attend late are treated by
optometrists who do not test for glaucoma, or more probably, they are
people who tend not to have regular sight tests.
The evidence for the latter interpretation is the finding that the risk
of late attendance is proportional to the number of years since the
patient last visited an optometrist (adjusted OR per year since last
visit, 1.25 [1.10,1.42]. Thus, those who attend for regular sight
tests seem more likely to seek medical attention in the early stages of
glaucoma. Although this may seem self-evident, there is little
published evidence to support the protective effect of regular sight
testing. These results lend weight to the concept that those who do not
have regular sight tests are at greater risk of late attendance.
However, the results contain a number of potential confounding factors.
Socioeconomic status (as measured by occupational categories) was shown
to be strongly associated with the risk of late attendance, with those
of highest socioeconomic status estimated to be at lowest risk of late
attendance. Corroborating evidence for this comes from
The
General Household Survey: Analysis of Ophthalmic Data 1990–91 to
1993–94, which was published in July 1995.
21 This
was a nationwide survey of private households in the United Kingdom,
with a sample size of between 23,000 and 24,000 people per year. In the
years studied, questions were included on use of spectacles, contact
lenses, and attendance for sight testing. The survey data indicate that
the highest percentage of those who attended for regular sight testing
were in occupational categories I and II with the lowest in categories
IV and V, consistent with our figures, which indicate a lower risk of
late attendance in these groups.
It has long been known that socioeconomic factors influence the access
to adequate medical care as well as patient compliance with
treatment,
22 and this extends to screening services.
Loehrer et al.
23 found that late attendance in various
cancers was directly related to lower socioeconomic status. They
thought that this was caused by both risk-promoting lifestyles and
beliefs about cancer based on incomplete or erroneous information.
Other studies have confirmed the link between later presentation and
social deprivation in those with breast,
24 colorectal,
25 and skin
26 cancers. It has also
been shown that lower socioeconomic class is associated with poor use
of screening services in mammography and cervical
smears.
27
As far as eye disease is concerned, Smith et al.,
28 examined the relationship between social deprivation and age of
attendance for amblyopia. They found that the more deprived children
are much more likely to attend late with anisometropic amblyopia. The
Baltimore Eye Study examined socioeconomic status and visual impairment
among urban Americans
29 and found that lower status is
associated with higher rates of visual impairment.
The finding in the present study that higher socioeconomic status was
associated with a reduced risk of late attendance is largely, but not
completely, explained by differences in sight testing rates. Even when
sight testing is adjusted for, as in
Table 3 , the difference in
socioeconomic status remains, indicating there may well be other
differences between the groups.
Family history of glaucoma was also found to be an important
determinant of disease stage at which medical attention is sought.
Those who reported a family history of glaucoma were one third as
likely to attend late as those who did not, and the more members of the
family with glaucoma, the more likely the patient was to attend early.
The reason for this result may be twofold: First, those with a positive
family history are more likely to appreciate the need for regular sight
testing because of information passed on from other members of the
family. Second, in the United Kingdom, all first-degree relatives of
patients with glaucoma are encouraged to have regular sight tests by
provision of free sight testing by the National Health Service.
People of African Caribbean origin were found, in the univariate model,
to have a much greater risk of late attendance than whites, consistent
with results of the pilot study. However, this risk was not
statistically significant after adjustment. As described in the results
section, this appears to be related to a lower attendance for sight
testing in the African Caribbean subjects.
Although there is no evidence that there was any statistical difference
between the IOPs of African Caribbeans and whites, this does not rule
out a faster rate of visual field loss. Lower socioeconomic status,
which is an important confounding factor, shows some correlation with
ethnic origin and is probably a further reason for a lower rate of
sight testing (and therefore late attendance).
Wilensky et al.
30 suggest that African Americans, for
socioeconomic reasons, do not seek medical care until glaucoma is more
advanced, although their report presents no evidence to support this.
There is, however, evidence that, compared with age-matched white
patients, black patients attend later in the course of certain
diseases, including prostate cancer,
31 32 breast
cancer,
33 and colorectal cancer.
34 Similarly,
there is evidence that African American populations use
health-screening services less than white patients.
35 Wells and Horm
33 showed that the racial differences of
disease stage at initial examination disappeared if socioeconomic class
was considered. Similarly, the Baltimore Eye Study identified an
association between race and blindness that was reduced, but not
eliminated, after adjustment for socioeconomic factors.
29 The results from the present study seem to indicate that poor use of
sight testing is an important risk factor for African Caribbean
patients attending the HES with advanced glaucomatous field loss.
Our pilot study
16 found a strong, linear relationship of
increasing age and increasing risk of late attendance. This is
unsurprising, because prevalence and incidence of glaucoma increase
with age, and the General Household Survey indicated a reduction in the
likelihood of sight testing in those aged more than 65 years in the
United Kingdom. Although not statistically significant, the results of
the present study show a general trend of increasing risk of late
attendance with age, with or without adjustment.
The pilot study also indicated that men are more likely to attend late
than women. Although there was a small protective effect for women in
the present study, it was lost after adjustment and, again, is not
statistically significant.
Patients who had a history of concurrent medical problems (the
assumption being that they had an increased involvement with medical
services and thus were more likely to be tested for glaucoma) were not
found to seek medical attention during earlier stages of glaucoma than
those who did not report any problems.
There are a number of potential biases in this study. Recall bias could
be a problem in collecting data on the previous sight test. This
information is related to the optometrist visit before the
visit that resulted in referral (if the patient was referred by an
optometrist), which may have been some time beforehand. This bias was
reduced, however, because the subjects recruited were unaware of their
own case–control status.
It is important to note that the data regarding IOP are one-off
measurements on first examination in the HES and, with later regression
to the mean, the individual IOPs could be different in subsequent
examinations, although this is less likely to affect the overall median
IOP. The nature of this study required that patients be recruited at
initial examination, which means that prolonged follow-up of the
patients has not yet occurred. Therefore, the findings regarding the
normal-tension glaucoma group
(Table 3) should be interpreted with
caution, because some of the patients may have had conversion to
primary open-angle glaucoma after longer follow-up or phasing.
Using three different sites in the study to recruit patients is
unlikely to have introduced any bias into the results, because the
patients were chosen with standard criteria listed earlier. Using three
geographically distinct centers (and using equal numbers of cases and
controls from each center) reduced the probability that the results
were from one unrepresentative center.
In conclusion, published evidence indicates that late attendance for
glaucoma appears to be associated with risk of subsequent blindness. In
this study the risk factors for late attendance itself were higher IOP,
infrequent sight testing, and lower socioeconomic status. Conversely, a
positive family history was likely to be associated with earlier
attendance.
The current system for glaucoma detection in the United Kingdom
relies almost exclusively on optometrists in private practice. A
patient requiring a sight test attends an optometrist who, if glaucoma
is suspected, refers the patient to a GP with the intention of onward
referral to an ophthalmologist in the HES. Although an optometrist
cannot refer a patient directly to the HES, the GP may. It is very rare
for the GP to have the expertise or equipment to examine for glaucoma,
which is why most referrals originate with the optometrist.
Participating centers: Moorfields Eye Hospital, London; Sunderland Eye
Hospital; Harold Wood Hospital, Essex, United Kingdom.
Supported by grants from the International Glaucoma Association and
Moorfields Locally Organised Research Scheme.
Submitted for publication September 29, 1998; revised March 18, 1999;
accepted March 29, 1999.
Proprietary interest category: N.
Corresponding author: Scott Fraser, Glaxo Department of Ophthalmic
Epidemiology, Moorfields Eye Hospital, City Road, London EC1V 2PD,
UK.
Table 1. Standard Occupational Classification Categories
Table 1. Standard Occupational Classification Categories
I | Professional occupations |
II | Managerial and technical occupations |
IIIN | Skilled occupations, manual |
IIIM | Skilled occupations, nonmanual |
IV | Partly skilled occupations |
V | Unskilled occupations |
Table 2. Study Factors by Case–Control Status
Table 2. Study Factors by Case–Control Status
Study Factor | Controls n1 | Cases n2 | OR | 95% CI |
Age | | | | |
≤40 | 8 | 9 | 1 | |
41–50 | 16 | 6 | 0.33 | (0.09, 1.27) |
51–60 | 26 | 7 | 0.24 | (0.07, 0.85) |
61–70 | 27 | 27 | 0.89 | (0.30, 2.65) |
71–80 | 29 | 47 | 1.44 | (0.50, 4.15) |
81–90 | 4 | 14 | 3.11 | (0.72, 13.44) |
Median | 63 (52, 71) | 72 (63, 78) | | |
Sex | | | | |
Male | 54 | 60 | 1 | |
Female | 56 | 50 | 0.8 | (0.47, 1.36) |
Ethnicity | | | | |
White | 98 | 73 | 1 | |
African Caribbean | 6 | 29 | 6.49 | (2.56, 16.44) |
Asian | 6 | 8 | 1.79 | (0.60, 5.38) |
Occupational group | | | | |
I | 5 | 0 | 0 | (0.00, 0.26) |
II | 27 | 1 | 0.01 | (0.00, 0.08) |
III | 56 | 42 | 0.20 | (0.09, 0.44) |
IV | 12 | 29 | 0.64 | (0.24, 1.67) |
V | 10 | 38 | 1 | |
Type of glaucoma | | | | |
Primary open-angle | 83 | 72 | 1 | — |
Pseudoexfoliative | 0 | 15 | ∞ | (4.98, ∞) |
Normal tension | 21 | 6 | 0.33 | (0.13, 0.87) |
Aphakic | 0 | 2 | ∞ | (0.32, ∞) |
Pigmentary | 4 | 1 | 0.29 | (0.03, 2.67) |
Traumatic | 1 | 2 | 2.33 | (0.21, 26.27) |
Chronic angle-closure | 0 | 13 | ∞ | (4.25, ∞) |
Median IOP (IQR) | | | | |
Right eye | 22.5 (20, 26) | 27 (22, 35) | | |
Left eye | 23 (20, 26) | 28 (23, 34) | | |
Maximum IOP (both eyes) | 25 (22, 27) | 30 (25, 38) | 1.17 | (1.11, 1.24) |
Medical problems | | | | |
Hypertension | 18 | 21 | | |
Diabetes mellitus | 5 | 4 | | |
Cerebrovascular accident (CVA) | 1 | 4 | | |
Ischemic heart disease | 1 | 2 | | |
Hypertension and diabetes | 1 | 3 | | |
Respiratory diseases | 5 | 7 | | |
Thyroid abnormalities | 4 | 7 | | |
Nonsignificant | 75 | 62 | | |
Combining medical problems | | | | |
No | | | 1 | |
Yes | | | 1.43 | (0.82, 2.49) |
Family history of glaucoma | | | | |
No | 62 | 93 | 1 | |
Second-degree relative | 9 | 5 | 0.36 | (0.12, 1.13) |
First-degree relative | 23 | 8 | 0.23 | (0.09, 0.54) |
More than one first-degree relative | 16 | 4 | 0.16 | (0.05, 0.51) |
Family history (combining last three categories) | | | 0.23 | (0.12, 0.44) |
Referral source | | | | |
Optometrists with correct diagnosis | 100 | 63 | 1 | |
Other | 10 | 47 | 7.46 | (3.52, 15.82) |
Last visit to optometrist before referral (y) | | | | |
1 | 27 | 12 | | |
2 | 45 | 23 | | |
3 | 16 | 10 | | |
5 | 12 | 15 | | |
6 | 0 | 1 | | |
10 | 5 | 23 | | |
>10 or never | 5 | 26 | | |
OR of last visit to optometrist before referral (y) | | | 1.29 | (1.18, 1.41) |
Table 3. Estimates of the Effect of Each Study Factor on Late Presnetation
Table 3. Estimates of the Effect of Each Study Factor on Late Presnetation
Study Factor | Adjusted OR* | 95% CI |
Age | | |
≤40 | | |
41–50 | 0.79 | (0.09, 6.99) |
51–60 | 0.15 | (0.02, 1.25) |
61–70 | 1.01 | (0.15, 6.90) |
71–80 | 1.82 | (0.30, 11.06) |
81–90 | 2.97 | (0.30, 29.35) |
Sex | | |
Male | 1 | |
Female | 1.23 | (0.53, 2.85) |
Ethnicity | | |
White | 1 | |
African Caribbean | 2.47 | (0.63, 9.72) |
Asian | 0.81 | (0.12, 5.67) |
Occupational group | | |
I | 0 | — |
II | 0.02 | (0.00, 0.16) |
III | 0.27 | (0.10, 0.80) |
IV | 0.95 | (0.26, 3.46) |
V | 1 | — |
Type of glaucoma | | |
Primary open-angle | 1 | — |
Pseudoexfoliative | — | — |
Normal tension | 3.04 | (0.63, 14.70) |
Aphakic | — | — |
Pigmentary | 1.55 | (0.03, 85.12) |
Traumatic | 0.18 | (0.00, >200) |
Chronic angle-closure | — | — |
Maximum IOP | 1.20 | (1.11, 1.28) |
Medical problems | | |
No | 1 | |
Yes | 1.01 | (0.43, 2.35) |
Family history of glaucoma | 0.29 | (0.12, 0.74) |
Referral source | | |
Optometrists and correct diagnosis | 1 | |
Other | 4.53 | (1.52, 13.48) |
Last visit to optometrist before referral (y) | 1.25 | (1.10, 1.42) |
The authors thank Rod Daniel, Peter Phelan, and Charles
Claoué for their help in recruiting the patients.
Tielsch JM, Sommer A, Katz J, Quigley HA, Royall RM, Javitt J. Racial variations in the prevalence of primary open angle glaucoma. JAMA
. 1991;266:369–374.
[CrossRef] [PubMed]Klein BEK, Klein R, Sponsel WE, et al. Prevalence of glaucoma. Ophthalmolgy
. 1992;99:1499–1504.
[CrossRef] Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol
. 1996;80:389–393.
[CrossRef] [PubMed]Tielsch JM, Sommer A, Witt K, Katz J, Royall RM. Blindness and visual impairment in an American urban population. Arch Ophthalmol
. 1990;108:286–290.
[CrossRef] [PubMed]Grant WM, Burke JF. Why do some people go blind from glaucoma?. Ophthalmology
. 1982;89:991–998.
[CrossRef] [PubMed]
Standard Occupational Classification. Office of Population
Censuses and Surveys. London: Her Majesty’s Stationery Office; 1991.
Stata Corporation. Stata Statistical Software. Release 5.0
College Station, TX: Stata; 1997.
Wilson R, Walker A, Dueker DK, Pitts-Crick R. Risk factors for rate of progression of glaucomatous visual field loss. Arch Ophthalmol
. 1982;100:737–742.
[CrossRef] [PubMed]Fruhauf A, Muller F, Sismuth M. Utersuchungen zur Prognose des Glaukoms. Klin Monatsbl Augenheilkd. 1967;151:477–485.
Hart WM, Becker B. The onset and evolution of glaucomatous visual field defects. Ophthalmology
. 1982;89:268.
[CrossRef] [PubMed]Sommer A, Quigley HA, Robin AL, Miller NR, Katz J, Arkell S. Evaluation of nerve fibre layer assessment. Arch Ophthalmol
. 1984;102:1766–1771.
[CrossRef] [PubMed]Mikelburg FS, Schulzer M, Drance SM, Lau W. The rate of progression of scotomas in glaucoma. Am J Ophthalmol
. 1986;101:1–6.
[CrossRef] [PubMed]Elkington AR, Lewry J, MacKean J, Sargent P. A collaborative hospital glaucoma survey. Res Clin Forums. 1982;4:31–40.
Coffey M, Reidy A, Wormald R, Wu XX, Wright L, Courtney P. Prevalence of glaucoma in the West of Ireland. Br J Ophthalmol
. 1993;77:17–21.
[CrossRef] [PubMed]Sheldrick JH, Ng C, Austin DJ, Rosenthal AR. An analysis of referral routes and diagnostic accuracy in cases of suspected glaucoma. Ophthalmic Epidemiol
. 1994;1:31–38.
[CrossRef] [PubMed]Fraser SG, Bunce CV, Wormald RPL. Retrospective analysis of risk factors for late presentation of chronic glaucoma. Br J Ophthalmol
. 1999;83:24–28.
[CrossRef] [PubMed]David R, Zangwill L, Stone D, Yassur Y. Epidemiology of intra-ocular pressure in a population screened for glaucoma. Br J Ophthalmol
. 1987;71:766–780.
[CrossRef] [PubMed]Hart WM, Yablonski M, Kass MA, Becker B. Multivariate analysis of the risk of glaucomatous field loss. Arch Ophthalmol
. 1979;97:1455–1458.
[CrossRef] [PubMed]Armaly MF, Krueger DE, Maunder L, et al. Biostatistical
analysis of the collaborative glaucoma study, I: summary of report of
the risk factors for glaucomatous visual field defects. Arch
Ophthalmol
. 1980;98:2163–2171.
[CrossRef] [PubMed]Jay JL, Murdoch JR. The rate of visual field loss in untreated primary open angle glaucoma. Br J Ophthalmol
. 1993;77:176–178.
[CrossRef] [PubMed]General Household Survey. Analysis of Ophthalmic Data 1990–91
to 1993–94. July 1995; Government Statistical Service London.
Leske MC, Rosenthal J. Epidemiological aspects of open angle glaucoma. Am J Epidemiol
. 1979;109:250–272.
[PubMed]Loehrer PJ, Greger HA, Weinberger M, et al. Knowledge and beliefs about cancer in a socioeconomically disadvantaged population. Cancer. 1991;69:1665–1671.
Wells BL, Horm JW. Stage at diagnosis in breast cancer: race and socioeconomic factors. Am J Public Health
. 1992;82:1383–1385.
[CrossRef] [PubMed]Powe BD. Fatalism amongst elderly African-Americans. Effects on colorectal cancer screening. Cancer Nurs
. 1995;18:385–392.
[PubMed]Robinson JK, Altman JS, Rademaker AW. Socioeconomic status and attitudes of 51 patients with giant basal and squamous cell carcinoma and paired controls. Arch Dermatol
. 1995;131:428–431.
[CrossRef] [PubMed]Calle EE, Flanders WD, Thun MJ, Martin LM. Demographic predictors of mammography and Pap smear screening in US women. Am J Public Health
. 1993;83:53–60.
[CrossRef] [PubMed]Smith LK, Thompson JR, Woodruff G, Hiscox F. Social deprivation and age at presentation in amblyopia. J Public Health Med
. 1994;16:348–351.
[PubMed]Tielsch JM, Sommer A, Katz J, Quigley H, Ezrine S. Socioeconomic status and visual impairment among urban Americans. Arch Ophthalmol. 1991;109:638–641.
Wilensky JT, Gandhi N, Pan T. Racial influences in open angle glaucoma. Ann Ophthalmol
. 1978;10:1398–1402.
[PubMed]Demark WW, Strigo T, Catoe K, et al. Knowledge, beliefs and prior screening behavior among blacks and whites reporting for prostate cancer screening. Urology
. 1995;46:346–351.
[CrossRef] [PubMed]Ndubuisi SC, Kofie VY, Andoh JY, Schwartz EM. Black–white differences in the stage at presentation of prostate cancer in the District of Columbia. Urology. 1995;46:71–77.
Wells BL, Horm JW. Stage at diagnosis in breast cancer: race and socioeconomic factors. Am J Public Health
. 1992;82:1383–1385.
[CrossRef] [PubMed]Powe BD. Fatalism amongst elderly African-Americans. Effects on colorectal cancer screening. Cancer Nurs
. 1995;18:385–392.
[PubMed]Womeodu RJ, Bailey JE. Barriers to cancer screening. Med Clin North Am
. 1996;80:115–133.
[CrossRef] [PubMed]